Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 111Lung Neoplasms 54Adenocarcinoma of Lung 10Breast Neoplasms 9Small Cell Lung Carcinoma 5Neoplasms 5Mesothelioma, Malignant 5NSCLC 4Mesothelioma 3Adenocarcinoma, Bronchiolo-Alveolar 3Thoracic Neoplasms 2Recurrence 2Prostatic Neoplasms 2Ovarian Neoplasms 2Non-small Cell Lung Cancer Metastatic 2Lung Diseases 2Carcinoma, Ovarian Epithelial 2Advanced Non-Small Cell Lung Cancer 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Solitary Fibrous Tumor, Pleural 1Sarcoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Pleural Effusion, Malignant 1Pheochromocytoma 1Paraganglioma, Extra-Adrenal 1Pancreatic Neoplasms 1Non-small Cell Lung Cancer Stage â…¡ 1

Interventions

Carboplatin 2sintilimab 1Vinorelbine 1Surgical Procedures, Operative 1Protons 1Paclitaxel 1Cisplatin 1Atovaquone 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Non-Small Cell Lung Cancer × Vinorelbine × Thoracic × Clear all
NCT04648033 2026-01-29

ARCADIAN

University of Oxford

Phase 1 Completed
21 enrolled 21 charts
Thoracic

Locally Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡